Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) FCF Margin (2016 - 2020)

Historic FCF Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 4113.42%.

  • Syndax Pharmaceuticals' FCF Margin fell 7642100.0% to 4113.42% in Q4 2020 from the same period last year, while for Sep 2021 it was 22949.74%, marking a year-over-year decrease of 184437400.0%. This contributed to the annual value of 1160.91% for FY2024, which is N/A changed from last year.
  • As of Q4 2020, Syndax Pharmaceuticals' FCF Margin stood at 4113.42%, which was down 7642100.0% from 4827.7% recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' FCF Margin ranged from a high of 1069.91% in Q4 2017 and a low of 5648.28% during Q2 2020
  • Moreover, its 5-year median value for FCF Margin was 3915.61% (2017), whereas its average is 3715.02%.
  • In the last 5 years, Syndax Pharmaceuticals' FCF Margin soared by 212229300bps in 2016 and then tumbled by -28924600bps in 2018.
  • Quarter analysis of 5 years shows Syndax Pharmaceuticals' FCF Margin stood at 3415.08% in 2016, then soared by 69bps to 1069.91% in 2017, then plummeted by -270bps to 3962.37% in 2018, then grew by 15bps to 3349.21% in 2019, then decreased by -23bps to 4113.42% in 2020.
  • Its FCF Margin was 4113.42% in Q4 2020, compared to 4827.7% in Q3 2020 and 5648.28% in Q2 2020.